nach oben

Journal of Neural Transmission

Erschienen in:

01.04.2013 | Neurology and Preclinical Neurological Studies - Review Article

Fatigue assessment of Parkinson’s disease patient in clinic: specific versus holistic

verfasst von: Cristian Falup-Pecurariu

Erschienen in: Journal of Neural Transmission | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Fatigue is a frequently encountered non-motor symptom in Parkinson’s disease (PD). Being a subjective definition, with no biological markers, it is difficult to describe. Its definition is influenced by the background and culture of the patient. Subtypes of fatigue are peripheral fatigue and mental fatigue. The co-existence of other non-motor symptoms in PD complicates its assessment. Fatigue could be present before, at the time of diagnosis of PD in untreated patients or during the course of the disease. Scales that can be used for evaluation include generic one for a holistic manner and those specifically designed for PD. A scale designed for fatigue should differentiate between PD patients with fatigue and those without fatigue. The next step is to choose between unidimensional which evaluate one dimension and multidimensional scales. We present the main scales which can be used for fatigue assessment and their properties. The scales are presented with some psychometric properties in non-PD population and those properties through validation in PD population. Scales have some properties which could be recommended for screening and/or rating of severity of fatigue in PD.

Abe K, Takanashi M, Yanagihara T (2000) Fatigue in patients with Parkinson’s disease. Behav Neurol 12(3):103–106PubMed

Alves G (2012) Fatigue rating scales in Parkinson’s disease. In: Sampaio C, Goetz CG, Schrag A (eds) Rating scales in Parkinson’s disease, Clinical practice and research. Oxford University Press, New York, pp 233–259

Alves G, Wentzel-Larsen T, Larsen JP (2004) Is fatigue an independent and persistent symptom in patients with Parkinson disease? Neurology 63(10):1908–1911PubMedCrossRef

American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (2000) Fourth Edition, Text Revision, Washington, DC, American Psychiatric Association

Brown RG, Dittner A, Findley L, Wessely SC (2005) The Parkinson fatigue scale. Parkinsonism Relat Disord 11(1):49–55PubMedCrossRef

Bryant MS, Rintala DH, Hou JG, Rivas SP, Fernandez AL, Lai EC, Protas EJ (2012) The relation of falls to fatigue, depression and daytime sleepiness in Parkinson’s disease. Eur Neurol 67(6):326–330PubMedCrossRef

Buchwald D, Pearlman T, Kith P, Schmaling K (1994) Gender differences in patients with chronic fatigue syndrome. J Gen Intern Med 9(7):397–401PubMedCrossRef

Chadhuri A, Behan PO (2000) Fatigue and basal ganglia. J Neurol Sci 179(S 1–2):34–42

Chaudhuri A, Behan PO (2004) Fatigue in neurological disorders. Lancet 363(9413):978–988PubMedCrossRef

Chaudhuri KR, Healy DG, Schapira AH (2006a) Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 5(3):235–245PubMedCrossRef

Chaudhuri KR, Martinez-Martin P, Schapira AH et al (2006b) International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord 21(7):916–923PubMedCrossRef

Chaudhuri KR, Martinez-Martin P, Brown RG et al (2007) The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: results from an international pilot study. Mov Disord 22(13):1901–1911PubMedCrossRef

David A, Pelosi A, McDonald E, Stephens D, Ledger D, Rathbone R, Mann A (1990) Tired, weak, or in need of rest: fatigue among general practice attenders. BMJ 301(6762):1199–1202PubMedCrossRef

Dittner AJ, Wessely SC, Brown RG (2004) The assessment of fatigue. A practical guide for clinicians and researchers. J Psychosom Res 56(2):157–170PubMedCrossRef

Elbers R, van Wegen EE, Rochester L, Hetherington V, Nieuwboer A, Willems AM, Jones D, Kwakkel G (2009) Is impact of fatigue an independent factor associated with physical activity in patients with idiopathic Parkinson’s disease? Mov Disord 24(10):1512–1518PubMedCrossRef

Fisk JD, Doble SE (2002) Construction and validation of a fatigue impact scale for daily administration (D-FIS). Qual Life Res 11(3):263–272PubMedCrossRef

Friedman JH, Friedman H (2001) Fatigue in Parkinson’s disease: a nine-year follow-up. Mov Disord 16(6):1120–1122PubMedCrossRef

Friedman JH, Brown RG, Comella C, Garber CE, Krupp LB, Lou JS, Marsh L, Nail L, Shulman L, Taylor CB, as the Working Group on Fatigue in Parkinson’s Disease (2007) Fatigue in Parkinson’s disease. Mov Disord 22(3):297–308CrossRef

Friedman JH, Alves G, Hagell P, Marinus J, Marsh L, Martinez-Martin P, Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins G, Schrag A (2010) Fatigue rating scales critique and recommendations by the movement disorders society task force on rating scales for Parkinson’s disease. Mov Disord 25(7):805–822PubMedCrossRef

Garber CE, Friedman JH (2005) Fatigue. In: Pfeiffer RF, Wollner IB (eds) Parkinson’s disease and nonmotor dysfunction. Humana Press, New York, pp 281–294CrossRef

Grace J, Mendelsohn A, Friedman JH (2007) A comparison of fatigue measures in Parkinson’s disease. Parkinsonism Relat Disord 13(7):443–445PubMedCrossRef

Hagell P, Höglund A, Reimer J, Eriksson B, Knutsson I, Widner H, Cella D (2006) Measuring fatigue in Parkinson’s disease: a psychometric study of two brief generic fatigue questionnaires. J Pain Symptom Manage 32(5):420–432PubMedCrossRef

Hagell P, Brundin L (2009) Towards an understanding of fatigue in Parkinson disease. J Neurol Neurosurg Psychiatry 80(5):489–492PubMedCrossRef

Hagell P, Rosblom T, Pålhagen S (2012) A Swedish version of the 16-item Parkinson fatigue scale (PFS-16). Acta Neurol Scand 125(4):288–292

Havlikova E, Rosenberger J, Nagyova I, Middel B, Dubayova T, Gdovinova Z, van Dijk JP, Groothoff JW (2008) Impact of fatigue on quality of life in patients with Parkinson’s disease. Eur J Neurol 15(5):475–480PubMedCrossRef

Herlofson K, Larsen JP (2003) The influence of fatigue on health-related quality of life in patients with Parkinson’s disease. Acta Neurol Scand 107(1):1–6PubMedCrossRef

Hjollund NH, Andersen JH, Bech P (2007) Assessment of fatigue in chronic disease: a bibliographic study of fatigue measurement scales. Health Qual Life Outcomes 5:12PubMedCrossRef

Hossain JL, Ahmad P, Reinish LW, Kayumov L, Hossain NK, Shapiro CM (2005) Subjective fatigue and subjective sleepiness: two independent consequences of sleep disorders? J Sleep Res 14:245–253PubMedCrossRef

Kluger BM, Friedman JH (2009) Fatigue in Parkinson’s disease. In: Chaudhuri KR, Tolosa E, Schapira A, Poewe W (eds) Non-motor symptoms of Parkinson’s disease. Oxford University Press, New York, pp 107–120

Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121–1123PubMedCrossRef

Kummer A, Scalzo P, Cardoso F, Teixeira AL (2011) Evaluation of fatigue in Parkinson's disease using the Brazilian version of Parkinson's Fatigue Scale. Acta Neurol Scand 123(2):130–136

Lou JS, Kearns G, Oken B, Sexton G, Nutt J (2001) Exacerbated physical fatigue and mental fatigue in Parkinson’s disease. Mov Disord 16(2):190–196PubMedCrossRef

Martinez-Martin P, Catalan MJ, Benito-Leon J, Moreno AO, Zamarbide I, Cubo E, van Blercon N, Arillo VC, Pondal M, Linazasoro G, Alonso F, Ruiz PG, Frades B (2006) Impact of fatigue in Parkinson’s disease: the fatigue impact scale for daily use (D-FIS). Qual Life Res 15(4):597–606PubMedCrossRef

Martinez-Martin P, Rodriguez-Blazquez C, Abe K, Bhattacharyya KB, Bloem BR, Carod-Artal FJ, Prakash R, Esselink RA, Falup-Pecurariu C, Gallardo M, Mir P, Naidu Y, Nicoletti A, Sethi K, Tsuboi Y, van Hilten JJ, Visser M, Zappia M, Chaudhuri KR (2009) International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease. Neurology 73(19):1584–1591PubMedCrossRef

Mizuno K, Tanaka M, Nozaki S, Yamaguti K, Mizuma H, Sasabe T, Sugino T, Shirai T, Kataoka Y, Kajimoto Y, Kuratsune H, Kajimoto O, Watanabe Y (2007) Mental fatigue-induced decrease in levels of several plasma amino acids. J Neural Transm 114(5):555–561PubMedCrossRef

Pavese N, Metta V, Bose SK, Chaudhuri KR, Brooks DJ (2010) Fatigue in Parkinson’s disease is linked to striatal and limbic serotonergic dysfunction. Brain 133(11):3434–3443PubMedCrossRef

Pawlikowska T, Chalder T, Hirsch SR, Wallace P, Wight DJ, Wessely SC (1994) Population based study of fatigue and psychosocial distress. BMJ 308(6931):736–763CrossRef

Rascol O, Fitzer-Attas CJ, Hauser R, Jankovic J, Lang A, Langston JW, Melamed E, Poewe W, Stocchi F, Tolosa E, Eyal E, Weiss YM, Olanow CW (2011) A double-blind, delayed-start trial of rasagiline in Parkinson’s disease (the ADAGIO study): pre-specified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes. Lancet Neurol 10(5):415–423PubMedCrossRef

Risdale L, Evans A, Jerrett W, Mandalia S, Osler K, Vora H (1993) Patients with fatigue in general practice: a prospective study. BMJ 307(6896):103–106CrossRef

Schifitto G, Friedman JH, Oakes D, Shulman L, Comella CL, Marek K, Fahn S, Parkinson Study Group ELLDOPA Investigators (2008) Fatigue in levodopa-naive subjects with Parkinson disease. Neurology 71(7):481–485CrossRef

Schwartz JE, Jandorf L, Krupp LB (1993) The measurement of fatigue: a new instrument. J Psychosom Res 37(7):753–762PubMedCrossRef

Smets EMA, Garseen B, Bonke B, Dehaes JCJM (1995) The multidimensional fatigue inventory (MFI). Psychometric properties of an instrument to assess fatigue. J Psychosom Res 39:315–325PubMedCrossRef

Taylor RR, Jasonn LA, Torres A (2000) Fatigue rating scales: an empirical comparison. Psychol Med 30:849–856PubMedCrossRef

van Hilten JJ, Weggeman M, van der Velde EA, Kerkhof GA, van Dijk JG, Roos RA (1993a) Sleep, excessive daytime sleepiness and fatigue in Parkinson’s disease. J Neural Transm Park Dis Dement Sect 5(3):235–244PubMedCrossRef

van Hilten JJ, Hoogland G, van der Velde EA, Middelkoop HA, Kerkhof GA, Roos RA (1993b) Diurnal effects of motor activity and fatigue in Parkinson’s disease. J Neurol Neurosurg Psychiatry 56(8):847–874

Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E (1997) Measuring fatigue and other anemia-related symptoms with the functional assessment of cancer therapy (FACT) measurement system. J Pain Symptom Manage 13(2):63–74PubMedCrossRef

Titel: Fatigue assessment of Parkinson’s disease patient in clinic: specific versus holistic
verfasst von: Cristian Falup-Pecurariu
Publikationsdatum: 01.04.2013
Verlag: Springer Vienna
Erschienen in: Journal of Neural Transmission / Ausgabe 4/2013
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-013-0969-1

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2013

Treatment of Parkinson’s disease in the advanced stage

The pharmacology of Tourette syndrome

Acoustic evaluation of short-term effects of repetitive transcranial magnetic stimulation on motor aspects of speech in Parkinson’s disease

Interdisziplinärer Arbeitskreis Bewegungsstörungen (IAB): an interdisciplinary working group for promoting multimodal therapy of movement disorders

Instruments for holistic assessment of Parkinson’s disease